Flex Pharma Inc. | Mutual Funds
Mutual Funds that own Flex Pharma Inc.
PRIMECAP Odyssey Aggressive Growth Fund
1,461,900
8.09%
2,269
0.01%
06/30/2018
Vanguard Investment Series Plc - US Opportunities Fund
336,200
1.86%
15,000
0.01%
06/30/2018
Columbia Small Cap Value Fund I
283,573
1.57%
-5,390
0.02%
05/31/2018
Royce Micro Cap Trust
264,274
1.46%
-64,346
0.03%
06/30/2018
Columbia Overseas Value Fund
216,716
1.2%
0
0.01%
05/31/2018
Vanguard Total Stock Market Index Fund
199,119
1.1%
0
0%
07/31/2018
Franklin Biotechnology Discovery Fund
170,200
0.94%
0
0.01%
03/31/2018
Columbia Variable - Small Cap Value Fund
164,435
0.91%
0
0.02%
05/31/2018
Vanguard Extended Market Index Fund
119,407
0.66%
0
0%
07/31/2018
Bridgeway Ultra Small Company Market Fund
65,189
0.36%
10,000
0.01%
12/31/2017
| Address |
31 St. James Avenue
Boston Massachusetts 02116
United States
|
|
Employees
|
- |
| Website |
http://www.flex-pharma.com |
| Updated |
07/08/2019 |
| Flex Pharma, Inc. operates as a biotechnology company. It engages in developing treatments for exercise-associated muscle cramps, nocturnal leg cramps and spasms associated with severe neuromuscular conditions. The company operates through the following business segments: Consumer Operations and Drug Development. |
